Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Intangibles (2016 - 2019)

Apyx Medical filings provide 10 years of Intangibles readings, the most recent being $185000.0 for Q2 2019.

  • On a quarterly basis, Intangibles fell 21.28% to $185000.0 in Q2 2019 year-over-year; TTM through Jun 2019 was $185000.0, a 21.28% decrease, with the full-year FY2018 number at $191000.0, up 185.07% from a year prior.
  • Intangibles hit $185000.0 in Q2 2019 for Apyx Medical, down from $190000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $1.5 million in Q2 2015 to a low of $32000.0 in Q3 2018.
  • Median Intangibles over the past 5 years was $252000.0 (2016), compared with a mean of $575611.1.
  • Biggest five-year swings in Intangibles: plummeted 87.48% in 2017 and later surged 703.19% in 2018.
  • Apyx Medical's Intangibles stood at $1.5 million in 2015, then tumbled by 85.76% to $215000.0 in 2016, then crashed by 68.84% to $67000.0 in 2017, then skyrocketed by 185.07% to $191000.0 in 2018, then fell by 3.14% to $185000.0 in 2019.
  • The last three reported values for Intangibles were $185000.0 (Q2 2019), $190000.0 (Q1 2019), and $191000.0 (Q4 2018) per Business Quant data.